Ray Dalio National Research Corp Transaction History

Bridgewater Associates, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$38.17 - $47.17 $30,077 - $37,169	788 Added 3.52%	23,162 $1.01 Million
Q4 2022 Feb 13, 2023	SELL	$35.23 - $41.21 $259,257 - $303,264	-7,359 Reduced 24.75%	22,374 $834,000
Q3 2022 Nov 10, 2022	SELL	$33.58 - $40.66 $3,458 - $4,187	-103 Reduced 0.35%	29,733 $1.18 Million
Q2 2022 Aug 11, 2022	BUY	$31.87 - $40.9 $121,520 - $155,951	3,813 Added 14.65%	29,836 $1.14 Million
Q1 2022 May 13, 2022	BUY	$36.33 - $42.25 $273,383 - $317,931	7,525 Added 40.68%	26,023 $1.03 Million
Q4 2021 Feb 14, 2022	SELL	$40.05 - $49.0 $151,268 - $185,073	-3,777 Reduced 16.96%	18,498 $768,000
Q3 2021 Nov 12, 2021	SELL	$42.17 - $54.5 $36,350 - $46,979	-862 Reduced 3.73%	22,275 $939,000
Q2 2021 Aug 13, 2021	BUY	$43.54 - $51.55 $1.01 Million - $1.19 Million	23,137 New	23,137 $1.06 Million

144

12.7M

300

300

Ticker NRC
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 24,767,100
Market Cap $416M
Description
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-re...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.